Your browser doesn't support javascript.
loading
Combination of pre-treatment dynamic [18F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma.
Li, Zhicong; Holzgreve, Adrien; Unterrainer, Lena M; Ruf, Viktoria C; Quach, Stefanie; Bartos, Laura M; Suchorska, Bogdana; Niyazi, Maximilian; Wenter, Vera; Herms, Jochen; Bartenstein, Peter; Tonn, Joerg-Christian; Unterrainer, Marcus; Albert, Nathalie L; Kaiser, Lena.
Affiliation
  • Li Z; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. lzc1225@163.com.
  • Holzgreve A; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
  • Unterrainer LM; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
  • Ruf VC; Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany.
  • Quach S; Department of Neurosurgery, University Hospital, LMU Munich, Munich, Germany.
  • Bartos LM; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
  • Suchorska B; Department of Neurosurgery, University Hospital, LMU Munich, Munich, Germany.
  • Niyazi M; Department of Neurosurgery, Sana Hospital, Duisburg, Germany.
  • Wenter V; Department of Radiotherapy, University Hospital, LMU Munich, Munich, Germany.
  • Herms J; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
  • Tonn JC; Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany.
  • Unterrainer M; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
  • Albert NL; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kaiser L; Department of Neurosurgery, University Hospital, LMU Munich, Munich, Germany.
Eur J Nucl Med Mol Imaging ; 50(2): 535-545, 2023 01.
Article in En | MEDLINE | ID: mdl-36227357
ABSTRACT

PURPOSE:

The aim of this study was to build and evaluate a prediction model which incorporates clinical parameters and radiomic features extracted from static as well as dynamic [18F]FET PET for the survival stratification in patients with newly diagnosed IDH-wildtype glioblastoma.

METHODS:

A total of 141 patients with newly diagnosed IDH-wildtype glioblastoma and dynamic [18F]FET PET prior to surgical intervention were included. Patients with a survival time ≤ 12 months were classified as short-term survivors. First order, shape, and texture radiomic features were extracted from pre-treatment static (tumor-to-background ratio; TBR) and dynamic (time-to-peak; TTP) images, respectively, and randomly divided into a training (n = 99) and a testing cohort (n = 42). After feature normalization, recursive feature elimination was applied for feature selection using 5-fold cross-validation on the training cohort, and a machine learning model was constructed to compare radiomic models and combined clinical-radiomic models with selected radiomic features and clinical parameters. The area under the ROC curve (AUC), accuracy, sensitivity, specificity, and positive and negative predictive values were calculated to assess the predictive performance for identifying short-term survivors in both the training and testing cohort.

RESULTS:

A combined clinical-radiomic model comprising six clinical parameters and six selected dynamic radiomic features achieved highest predictability of short-term survival with an AUC of 0.74 (95% confidence interval, 0.60-0.88) in the independent testing cohort.

CONCLUSIONS:

This study successfully built and evaluated prediction models using [18F]FET PET-based radiomic features and clinical parameters for the individualized assessment of short-term survival in patients with a newly diagnosed IDH-wildtype glioblastoma. The combination of both clinical parameters and dynamic [18F]FET PET-based radiomic features reached highest accuracy in identifying patients at risk. Although the achieved accuracy level remained moderate, our data shows that the integration of dynamic [18F]FET PET radiomic data into clinical prediction models may improve patient stratification beyond established prognostic markers.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioblastoma / Glioma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2023 Document type: Article Affiliation country: Alemania

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioblastoma / Glioma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2023 Document type: Article Affiliation country: Alemania
...